AU2017245414A1 - The cure for cancer - Google Patents
The cure for cancer Download PDFInfo
- Publication number
- AU2017245414A1 AU2017245414A1 AU2017245414A AU2017245414A AU2017245414A1 AU 2017245414 A1 AU2017245414 A1 AU 2017245414A1 AU 2017245414 A AU2017245414 A AU 2017245414A AU 2017245414 A AU2017245414 A AU 2017245414A AU 2017245414 A1 AU2017245414 A1 AU 2017245414A1
- Authority
- AU
- Australia
- Prior art keywords
- cancer
- cure
- months
- subject
- period
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 239000003245 coal Substances 0.000 abstract 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A method of treating cancer by administering coal to a subject for a period of three to six months.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017245414A AU2017245414A1 (en) | 2017-10-13 | 2017-10-13 | The cure for cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017245414A AU2017245414A1 (en) | 2017-10-13 | 2017-10-13 | The cure for cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2017245414A1 true AU2017245414A1 (en) | 2019-05-09 |
Family
ID=66329356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2017245414A Abandoned AU2017245414A1 (en) | 2017-10-13 | 2017-10-13 | The cure for cancer |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2017245414A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10318952B1 (en) | 2015-05-23 | 2019-06-11 | Square, Inc. | NFC base station and passive transmitter device |
| US10402816B2 (en) | 2016-12-31 | 2019-09-03 | Square, Inc. | Partial data object acquisition and processing |
| US11113698B2 (en) | 2017-02-22 | 2021-09-07 | Square, Inc. | Line-based chip card tamper detection |
-
2017
- 2017-10-13 AU AU2017245414A patent/AU2017245414A1/en not_active Abandoned
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10318952B1 (en) | 2015-05-23 | 2019-06-11 | Square, Inc. | NFC base station and passive transmitter device |
| US10402816B2 (en) | 2016-12-31 | 2019-09-03 | Square, Inc. | Partial data object acquisition and processing |
| US10970708B2 (en) | 2016-12-31 | 2021-04-06 | Square, Inc. | Predictive data object acquisition and processing |
| US11113698B2 (en) | 2017-02-22 | 2021-09-07 | Square, Inc. | Line-based chip card tamper detection |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2018067512A8 (en) | Spirocyclic compounds | |
| MX2021004007A (en) | Multivalent regulatory t cell modulators. | |
| MY198613A (en) | Nitrobenzyl derivatives of anti-cancer agents | |
| NZ730809A (en) | Methods for treating filoviridae virus infections | |
| PH12016502062B1 (en) | Compositions and methods for modulating complement factor b expression | |
| MX2023011187A (en) | Methods of treating prostate cancer. | |
| AU2015299431B2 (en) | Pyrrolidinone derivatives as metAP-2 inhibitors | |
| MX2017006454A (en) | Sublingual administration of riluzole. | |
| EP4039247A3 (en) | Sublingual formulation of riluzole | |
| MY201580A (en) | Use of ezh2 inhibitor combined with btk inhibitor in preparing drug for treating tumor | |
| TN2019000210A1 (en) | Antitumoral compounds | |
| MX2016009663A (en) | Icariin derivatives. | |
| MX379622B (en) | Spirocyclic compounds | |
| EP4286005A3 (en) | Cancer treatment | |
| PH12020551791A1 (en) | Methods for the production of methacrylates | |
| AU2017247004A1 (en) | Method of treating atherosclerosis | |
| PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| MX2016016388A (en) | Method of treating non-small cell lung cancer and/or small cell lung cancer using thienotriazolodiazepine compounds. | |
| MX2017014436A (en) | Bicyclic compounds. | |
| EP4324477A3 (en) | Oxabicycloheptanes for modulation of immune response | |
| MY177465A (en) | A microorganism of the genus escherichia producing l-tryptophan and a method for producing l-tryptophan using the same | |
| AU2017245414A1 (en) | The cure for cancer | |
| MX2019014291A (en) | Treatment method. | |
| EP4470624A3 (en) | Methods of administering anti-fibrotic therapy | |
| MX2020005454A (en) | Improved treatment of cancer. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |